• Aucun résultat trouvé

Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants

N/A
N/A
Protected

Academic year: 2022

Partager "Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants"

Copied!
30
0
0

Texte intégral

Références

Documents relatifs

effectiveness evaluation.10,11 Participants retained for the fi nal anal- ysis were those with COVID-19; infection with either the original virus, the B.1.1.7 lineage, or the

Furthermore, as the attack rate among the unvaccinated increases (i.e. high transmission in community) the sample size needed decreases. If the vaccine is highly effective,

WHO has advised that countries with existing hospital-based sentinel influenza surveillance adapt these systems to also monitor severe SARS-CoV-2 cases (2), and collect data

We provide a new alignment-free method based on compression to determine the phylogeny and taxonomy of the SARS-CoV-2 virus (the virus causing the COVID-19 pandemic).. The method

Fisher’s exact test was used to analyze differences in antibody detection between the COVID19 + household group and the unknown status household group, as well as

We have proposed an attack on three variants of the RSA cryptosystem, namely the Kuwakado-Koyama-Tsuruoka extension for singular elliptic curves, Elkamchouchi et al.’s extension of

When an ACTN1 variant was identified via targeted ACTN1 DNA sequence analysis, the DNA sample was also analyzed using the 50 ‐ gene panel to exclude the presence of other

In this note we compute the minimum size of identifying codes, locating-dominating codes, and total-dominating codes in Sierpi´ nski